Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies

• Andrew M. K. Law,
• Andrew M. K. Law,
• Laura Rodriguez de la Fuente,
• Laura Rodriguez de la Fuente,
• Laura Rodriguez de la Fuente,
• Thomas J. Grundy,
• Guocheng Fang,
• Fatima Valdes-Mora,
• Fatima Valdes-Mora,
• David Gallego-Ortega,
• David Gallego-Ortega,
• David Gallego-Ortega

Affiliations

Andrew M. K. Law

Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Andrew M. K. Law

St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia

Laura Rodriguez de la Fuente

Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Laura Rodriguez de la Fuente

St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia

Laura Rodriguez de la Fuente

Cancer Epigenetic Biology and Therapeutics Lab, Children’s Cancer Institute, Randwick, NSW, Australia

Thomas J. Grundy

Life Sciences, Inventia Life Science Pty Ltd, Alexandria, NSW, Australia

Guocheng Fang

School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia

Fatima Valdes-Mora

Cancer Epigenetic Biology and Therapeutics Lab, Children’s Cancer Institute, Randwick, NSW, Australia

Fatima Valdes-Mora

School of Women’s and Children’s Health, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia

David Gallego-Ortega

Tumour Development Group, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

David Gallego-Ortega

St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Randwick, NSW, Australia

David Gallego-Ortega

School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia